The “Medications for OUD and Criminal Justice Systems and Settings” webinar, presented by faculty expert, Dr. Joshua Lee, will describe recent trends in criminal justice system (CJS) populations and intersections with the US opioid epidemic, detail clinical trials examining the application of medication-assisted treatment in CJS populations, and give context to recent and proposed policies impacting CJS and opioid use disorders.

Learning Objectives

• Analyze and interpret recent clinical trial data for OUD medications in criminal justice system (CJS) settings.
• Compare and contrast the practical and unique barriers and differences between MOUDs in CJS.
• List the advantages and disadvantages of daily versus long-acting MOUD formulations in a case-based framework.

Target Audience

Psychiatrists

Estimated Time to Complete

Estimated Duration: 1 hour
Begin Date: October 13, 2020
End Date: October 13, 2023

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned.

Accreditation

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Psychiatric Association designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Presenters

• Joshua Lee, MD, MSc; Associate Professor, Department of Population Health, NYU School of Medicine. Dr. Lee discloses the following relationships: Grant/Research: NYU Site PI of an ISS study funded by Indivior to Friends Research Institute. In-kind study drug for three recent or current NIH-funded trials from Indivior and Alkermes

Program Planners

• John Renner, M.D. Dr. Renner discloses the following relationship:APA Publishing royalties for the handbook Office-Based Buprenorphine for the treatment of Opioid Use Disorder

Accessibility for Participants with Disabilities

The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.

Technical Requirements

This internet-based CME activity is best experienced using any of the following:

• The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
• Internet Explorer 11+

This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

• Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
• Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
• Internet Connection: 1 Mbps or higher

Minimum Requirements:

• Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
• Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content

For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance